Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prince Street Capital Management is a New York-based hedge fund and investment adviser founded in 2001 by David C. Halpert. The firm specializes in managing long/short equity and absolute return strategies for institutional investors with a focus on global emerging and frontier market equities[3][4][5]. It manages several pooled investment funds structured as master-feeder funds domiciled in Bermuda and Delaware[5].
The company has no clinical programs or results as it does not operate in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prince Street Capital Management.